Ermenegildo Zegna NV
ZGN
DexCom
DXCM
New Fortress Energy
NFE
Workday
WDAY
eBay
EBAY
US Stock MarketDetailed Quotes
BLU BELLUS Health
- 14.740
- 0.0000.00%
Close Jun 29 09:30 ET
1.87BMarket Cap-20.19P/E (TTM)
0.000High0.000Low0Volume0.000Open14.740Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)126.81MShares14.76052wk High5.07P/B1.39BFloat Cap14.73052wk Low--Dividend TTM94.60MShs Float14.760Historical High--Div YieldTTM0.00%Amplitude2.010Historical Low--Avg Price1Lot Size
About BELLUS Health Company
BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, a P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, the development of drug candidates for health solutions.
Company Profile
SymbolBLU
Company NameBELLUS Health
CEOMr. Roberto Bellini
MarketNASDAQ
Employees74
Fiscal Year Ends12-31
Websitehttp://www.bellushealth.com
Company Executives
- Name
- Position
- Salary
- Roberto Bellini
- Director, President and Chief Executive Officer
- --
- Dr. Catherine Bonuccelli
- Chief Medical Officer
- --
- Ramzi Benamar
- Chief Financial Officer
- --
- Dr. Andreas Orfanos
- Chief Operating Officer
- --
- Dr. Denis Garceau
- Chief Scientific Officer
- --
- Francois Desjardins
- Senior Vice President, Finance
- --
- Tony Matzouranis
- Senior Vice President, Business Development
- --
- Dr. Francesco Bellini,PhD
- Chairman of the Board
- --
- William Mezzanotte
- Director
- --
- Pierre Larochelle
- Lead Independent Director
- --
- Dr. Clarissa Desjardins, PhD
- Independent Director
- --
- Franklin M. Berger, C.F.A.
- Independent Director
- --
- Joseph Rus
- Independent Director
- --
- Youssef L. Bennani
- Independent Director
- --
- Sebastien Roy
- Corporate Secretary
- --